教育講演
機能的画像 Update
2018 年 35 巻 4 号 p. 412-415
詳細
2018 年 35 巻 4 号 p. 412-415
Outstanding progress in functional neuroimaging has been recently achieved prominently in molecular imaging using nuclear medicine techniques. Amyloid PET, tau PET, and dopamine transporter SPECT have been applied to dementia and movement disorders for early diagnosis, differential diagnosis, and evaluation of effects of disease modifying drugs not only in clinical research or trial but also in routine clinical studies. Quantification of amyloid and tau deposition or striatal dopamine transporter is necessary for diagnosis.
